Thyroid Cancer in United Arab Emirates
NCT04763122 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 762
Last updated 2021-02-21
Summary
The main objective of the study is to assess the trend of clinicopathological features and treatment modalities in patients with thyroid cancer in the largest oncology center in the United Arab Emirates (UAE).
Conditions
- Thyroid
- Cancer
Interventions
- OTHER
-
not applicable as it is a retrospective study
It is a retrospective study
Sponsors & Collaborators
-
Tawam Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-09-30
- Primary Completion
- 2018-12-31
- Completion
- 2020-12-31
More Related Trials
-
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
NCT06268600 ·Status: RECRUITING ·Phase: NA
-
A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours
NCT01736163 ·Status: COMPLETED
-
The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up
NCT03699098 ·Status: COMPLETED ·Phase: NA
-
To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.
NCT03669432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
NCT04411290 ·Status: UNKNOWN
-
No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
NCT07115810 ·Status: COMPLETED
-
I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer
NCT01704586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer
NCT00389441 ·Status: COMPLETED ·Phase: PHASE2
-
Medico-Economic Comparison of Four Strategies of Radioiodine Ablation in Thyroid Carcinoma Patients
NCT00435851 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer
NCT06362772 ·Status: COMPLETED
-
Minimize Radioactive Iodine Ablation Of Remnant Thyroid in Differentiated Thyroid Cancer
NCT02418247 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
NCT04619316 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-term Survival Outcomes of Total Thyroidectomy and Radioactive Iodine Therapy in Unilateral T3/T4 FTC
NCT06437873 ·Status: COMPLETED
-
Iodine I 131 in Treating Patients With Thyroid Cancer
NCT00416949 ·Status: TERMINATED ·Phase: NA
-
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
NCT03841617 ·Status: RECRUITING ·Phase: PHASE2
-
HRQOL in Locally Advanced Thyroid Carcinoma
NCT05824312 ·Status: RECRUITING
-
Clinical and Surgical Outcomes of Thyroid Carcinoma in Children and Adolescents
NCT06592118 ·Status: COMPLETED
-
Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.
NCT00001730 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer
NCT05733013 ·Status: RECRUITING
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
NCT02706743 ·Status: UNKNOWN
-
Impact of Conventional Treatments and Clinical Variables on Thyroid Cancer
NCT05752604 ·Status: RECRUITING
-
Efficacy and Safety Study of rhTSH for Adjuvant Radioiodine Ablation Therapy in Patients With Differentiated Thyroid Cancer
NCT04964284 ·Status: RECRUITING ·Phase: PHASE3
-
I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer
NCT06443866 ·Status: RECRUITING
-
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
NCT06325787 ·Status: COMPLETED ·Phase: NA